Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Barriers and Opportunities of Oncofertility Practice in Nine Developing Countries and the Emerging Oncofertility Professional Engagement Network.

JCO global oncology·2022
Same author

Corrigendum: Fertility Preservation for Child and Adolescent Cancer Patients in Asian Countries.

Frontiers in endocrinology·2020
Same author

Barriers and Opportunities of Oncofertility Practice in Nine Developing Countries and the Emerging Oncofertility Professional Engagement Network.

Journal of global oncology·2020
Same author

Fertility Preservation for Child and Adolescent Cancer Patients in Asian Countries.

Frontiers in endocrinology·2019
Same author

Establishing an Anti-Müllerian Hormone Cutoff for Diagnosis of Polycystic Ovarian Syndrome in Women of Reproductive Age-Bearing Indian Ethnicity Using the Automated Anti-Müllerian Hormone Assay.

Journal of human reproductive sciences·2019
Same author

The Development of an International Oncofertility Competency Framework: A Model to Increase Oncofertility Implementation.

The oncologist·2019

Related Experiment Video

Updated: Mar 30, 2026

Author Spotlight: A Reproductive Hysteroscopy Approach for Complete Endometrial Polyp Removal and Enhanced Endometrial Receptivity
03:01

Author Spotlight: A Reproductive Hysteroscopy Approach for Complete Endometrial Polyp Removal and Enhanced Endometrial Receptivity

Published on: August 2, 2024

2.4K

Endometrial receptivity array: Clinical application.

Nalini Mahajan1

  • 1Department of Reproductive Medicine, Nova IVI Fertility, New Delhi, India.

Journal of Human Reproductive Sciences
|November 6, 2015
PubMed
Summary
This summary is machine-generated.

Diagnosing endometrial receptivity (ER) is challenging. The ER array (ERA) test identifies a displaced window of implantation (WOI) in recurrent implantation failure (RIF) patients, improving pregnancy rates with personalized embryo transfer (pET).

Keywords:
ERAEndometrial receptivityin-vitro fertilizationrecurrent implantation failurethin endometrium

More Related Videos

Author Spotlight: Multiplex Immunohistochemistry for Understanding Immune Regulation by Uterine NK Cells in Pregnancy
08:29

Author Spotlight: Multiplex Immunohistochemistry for Understanding Immune Regulation by Uterine NK Cells in Pregnancy

Published on: October 25, 2024

2.1K
Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage
05:16

Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage

Published on: August 4, 2021

4.0K

Related Experiment Videos

Last Updated: Mar 30, 2026

Author Spotlight: A Reproductive Hysteroscopy Approach for Complete Endometrial Polyp Removal and Enhanced Endometrial Receptivity
03:01

Author Spotlight: A Reproductive Hysteroscopy Approach for Complete Endometrial Polyp Removal and Enhanced Endometrial Receptivity

Published on: August 2, 2024

2.4K
Author Spotlight: Multiplex Immunohistochemistry for Understanding Immune Regulation by Uterine NK Cells in Pregnancy
08:29

Author Spotlight: Multiplex Immunohistochemistry for Understanding Immune Regulation by Uterine NK Cells in Pregnancy

Published on: October 25, 2024

2.1K
Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage
05:16

Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage

Published on: August 4, 2021

4.0K

Area of Science:

  • Reproductive Medicine
  • Genomics
  • Embryology

Background:

  • Accurate diagnosis of endometrial receptivity (ER) is crucial for human implantation but remains challenging due to subjective and inaccurate tests.
  • Microarray technology has identified the transcriptomic signature of the window of implantation (WOI), leading to the development of molecular diagnostic tools.

Purpose of the Study:

  • To evaluate the efficacy of the Endometrial Receptivity Array (ERA) test in diagnosing ER and improving reproductive outcomes in patients with recurrent implantation failure (RIF).
  • To assess the utility of ERA in patients with thin endometrium and its impact on pregnancy rates.

Main Methods:

  • The Endometrial Receptivity Array (ERA) test, a molecular diagnostic tool based on microarray technology, was used to determine ER.
  • Personalized embryo transfer (pET) was performed on the day designated by ERA in patients with RIF.
  • ERA was also conducted in patients with persistently thin endometrium (≤6 mm).

Main Results:

  • An endometrial factor was identified in 27.5% of Indian RIF patients, significantly higher than in the non-RIF group (15%).
  • Personalized embryo transfer (pET) resulted in an overall ongoing pregnancy rate of 42.4% and an implantation rate of 33%.
  • In patients with thin endometrium, 75% showed receptive endometrium, achieving a 66.7% pregnancy rate.

Conclusions:

  • The ERA test is a valuable tool for diagnosing ER, particularly in identifying displaced WOI in RIF patients.
  • Personalized embryo transfer guided by ERA significantly improves reproductive performance in RIF patients.
  • ERA demonstrates potential in assessing ER even in cases of thin endometrium, offering a promising diagnostic approach.